Abstract
The objectives of the study are to analyze the clinical and pathological features of 35 Chinese patients with late onset lupus nephritis (LN) in a single center. All the LN patients followed-up in our lupus clinic center from 1986 to 2008 were enrolled in this retrospective study. Thirty-five patients with a disease onset beyond the age of 50 years were identified. One hundred systemic lupus erythematosus (SLE) patients who had their disease onset before the age of 50 years were randomly recruited as controls. All of them received renal biopsy. The histological classifications were categorized according to 2003 International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification. All of patients were Han Chinese. The mean age of onset of SLE for late onset and the control groups were 55.7 ± 6.5 years (range: 50–76) and 28.9 ± 7.6 years (range:18–48).The female to male ratio was smaller in the late onset SLE group, 2.9–1, compared with 7.3–1 in the control. The patients with hypertension in late onset LN were much more than that in control group. The renal histological classes showed no significant difference between the two groups. Classes IV, V, IV + V were common in late onset LN patients. There were no significant differences in extra renal manifestations except for a lower prevalence of malar rash, a higher leukopenia and skin vasculitis in the late onset patients. As to the immunological features, serum antineutrophil cytoplasmic antibodies (ANCA) and SSA positivity were more common in late onset LN patients. The patients with hypertension in late onset LN were much more than that in control group. The renal histological classes showed no significant difference between the two groups. Leukopenia and serum ANCA were more common. The results suggest a more severity of the disease in late onset LN.
Similar content being viewed by others
References
Ward MM, Polisson PR (1989) A meta analysis of the clinical manifestations of older onset systemiclupus erythematosus. Arthritis Rheum 32:1226–1232
Hahn BH, Tsao BP (1997) Antibodies to DNA. In: Wallance DJ, Hahn BH (eds) Dubois’ lupus erythematosus. Williams and Wilkins, Baltimore, pp 407–422
Antolin J, Amerigo MJ et al (1995) Systemic lupus erythematosus: clinical manifestations and immunological parameters in 194 patients. Subgroup classification of SLE. Clin Rheumatol 14(6):678–685
Baker SB, Rovira JR et al (1979) Late onset systemic lupus erythematosus. Am J Med 66(5):727–732
Boddaert J, Huong DL et al (2004) Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltimore) 83(6):348–359
Appenzeller S, Pereira DA et al (2008) Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study. Lupus 17(11):1023–1028
Padovan M, Govoni M, Castellino G, Rizzo N, Fotinidi M, Trotta F (2007) Late onset systemic lupus erythematosus: no substantial differences using different cut-off ages. Rheumatol Int 27:735–741
Mok CC, Mak A, Chu WP, To CH, Wong SN (2005) Long-term survival of Southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Williams and Wilkins 84:218–224
Mak A, Mok CC, Chu WP, To CH, Wong SN, Au TC (2007) Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups. Lupus 16:28–34
Formiga F, Moga I et al (1999) Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. SLE disease activity index. Lupus 8(6):462–465
Baker SB, Rovira JR, Campion EW, Mills JA (1979) Late on-set systemic lupus erythematosus. Am J Med 66:727–732
Rovensky J, Tuchynova A (2008) Systemic lupus erythematosus in the elderly. Autoimmun Rev 7:235–239
Ho CTK, Mok CC, Lau CS, Wong RW (1998) Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis 57:437–440
Bertoli AM, Alarcon GS et al (2006) Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease. Arthritis Rheum 54(5):1580–1587
Boey ML (1998) Systemic lupus erythematosus in Singapore. Ann Acad Med Singapore 27(1):35–41
Karoubi Nordon E, Hayem G, Mentre F, Palazzo E, Legrain S, Meyer O, Raveaud P (2007) Letter to the editor: late onset systemic lupus erythematosus: a new approach. Lupus 16:1011–1014
Koh ET, Boey ML (1994) Late onset lupus: a clinical and immunological study in a predominantly Chinese population. J Rheumatol 21(8):1463–1467
Shaikh SK, Wang F (1995) Late-onset systemic lupus erythematosus: clinical and immunological characteristics. Med J Malaysia 50(1):25–31
Mak SK, Lam EK et al (1998) Clinical profile of patients with late-onset SLE: not a benign subgroup. Lupus 7(1):23–28
Sayarlioglu M, Cefle A et al (2005) Characteristics of patients with late onset systemic lupus erythematosus in Turkey. Int J Clin Pract 59(2):183–187
Steinberg AD, Melez KA et al (1979) Approach to the study of the role of sex hormones in autoimmunity. Arthritis Rheum 22(11):1170–1176
Bynoe MS, Grimaldi CM et al (2000) Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells. Proc Natl Acad Sci U S A 97(6):2703–2708
Chang DM, Lan JL et al (2002) Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum 46(11):2924–2927
Jungers P, Dougados M et al (1982) Effect of hormonal contraception on the course of lupus nephropathy. Nouv Presse Med 11(51):3765–3768
Jungers P, Liote F et al (1986) Hormonal modulation in disseminated lupus erythematosus: the preliminary results with danazol and cyproterone acetate. Ann Med Interne (Paris) 137(4):313–319
Mok CC, Lau CS et al (1999) Do flares of systemic lupus erythematosus decline after menopause? Scand J Rheumatol 28(6):357–362
Mok CC, Lau CS et al (1998) Safety of hormonal replacement therapy in postmenopausal patients with systemic lupus erythematosus. Scand J Rheumatol 27(5):342–346
Mok CC, Lau CS et al (2001) Use of exogenous estrogens in systemic lupus erythematosus. Semin Arthritis Rheum 30(6):426–435
Sanchez-Guerrero J, Liang MH et al (1995) Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus. Ann Intern Med 122(6):430–433
Mok CC, Wong RW et al (1999) Ovarian failure and flares of systemic lupus erythematosus. Arthritis Rheum 42(6):1274–1280
Kanda N, Tsuchida T et al (1999) Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 42(2):328–337
Maddison PJ (1987) Systemic lupus erythematosus in the elderly. J Rheumatol Suppl 14 Suppl 13:182–187
Rovensky J, Tuchynova A (2008) Systemic lupus erythematosus in the elderly. Autoimmun Rev 7(3):235–239
Garcia-Carrasco M, Ramos-Casals M et al (2002) Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore) 81(4):270–280
Jennette JC, Wilkman AS et al (1989) Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 135(5):921–930
Gross WL (1995) Antineutrophil cytoplasmic autoantibodies, autoantigens, and systemic vasculitis. Apmis 103(2):81–97
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tang, Z., Chen, D., Yang, S. et al. Late onset lupus nephritis: analysis of clinical manifestations and renal pathological features in Chinese patients. Rheumatol Int 31, 1625–1629 (2011). https://doi.org/10.1007/s00296-010-1536-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-010-1536-9